Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

2004 – LAP-BAND erosion found to be five times higher than advertised

Posted in Allergan LAP-BAND

We are no longer accepting cases regarding these products.  Due to a terrible Supreme Court ruling, consumers injured by this product are no longer permitted to sue the manufacturers of this device.  We wish we could help, but the Supreme Court has taken the rights of citizens away to protect the profits of medical device manufacturers.  For more information, please read the following New York Times article entitled “Medical Device Ruling Redraws Lines on Lawsuits.

In 2004, a study published in Obesity Surgery by M. Suter et al. and titled “Band erosion after laparoscopic gastric banding: occurrence and results after conversion to Roux-en-Y gastric bypass.” aimed to determine success rates of converting failed gastric banding procedures to gastric bypass.

While this study found that in general, conversions went well and patient weight loss continued with gastric bypass in a comparable way, it also revealed some important information about the safety of laparoscopic adjustable gastric banding with systems such as LAP-BAND.

The Allergan LAP-BAND Warning Label states that about 1.33% of patients will suffer LAP-BAND migration (erosion), but this study found that of 347 patients, 6.8% suffered LAP-BAND erosion, an erosion rate about five times higher than advertised.

Due to the fact that Allergan, the manufacturer of the LAP-BAND, has failed time and again to accurately portray the rate at which serious complications are associated with its product, a number of LAP-BAND lawsuits are currently being filed against the company.

 

Our Allergan LAP-BAND Lawsuit Information page is a great place to start if you have any questions about the Allergan LAP-BAND.